EX-23.1 5 v433718_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1 

 

Consent of Independent Registered Public Accounting Firm

 

Acura Pharmaceuticals, Inc.

Palatine, Illinois

 

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated February 29, 2016, relating to the consolidated financial statements of Acura Pharmaceuticals, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

/s/ BDO USA, LLP

Chicago, Illinois

March 9, 2016